Evidence map›Paper›PMID 20600583›Full record

ReviewMolecular and cellular endocrinology2010

Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states.

Amani Batarseh, Vassilios Papadopoulos

Abstract readReview
In one paragraph

Review in Molecular and cellular endocrinology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 127 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
127citing papers in PubMed, 1 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

127 citing papers in PubMed, 1 synthesis or guideline pooled it, 267 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Role of Mitochondrial Dysfunction in Neuropathy.International journal of molecular sciences · 2025
    Review
  11. Enhanced resistance toFrontiers in pharmacology · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. A first-in-man study of [Annals of nuclear medicine · 2024
    Article
  18. Review
  19. Frontiers in toxicology · 2024
    Article
  20. Article

67 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Amani BatarsehDepartment of Biochemistry and Molecular and Cell Biology, Georgetown University Medical Center, Washington, DC 20057, USA.
Vassilios Papadopoulos
Georgetown University Medical Center · USMcGill University Health Centre · CA

Funding

Role of Benzodiazepine Receptor in Leydig Cell FunctionR01ES007747 · NIEHS · MCGILL UNIVERSITY HEALTH CTR RES INST · PI PAPADOPOULOS, VASSILIOS · 1995 to 2011
$3.5M
NIEHS NIH HHS R01 ES007747NIEHS NIH HHS R01 ES07747
6 · The paper itself

Abstract

Translocator protein (TSPO) is an 18 kDa high affinity cholesterol- and drug-binding protein found primarily in the outer mitochondrial membrane. Although TSPO is found in many tissue types, it is expressed at the highest levels under normal conditions in tissues that synthesize steroids. TSPO has been associated with cholesterol import into mitochondria, a key function in steroidogenesis, and directly or indirectly with multiple other cellular functions including apoptosis, cell proliferation, differentiation, anion transport, porphyrin transport, heme synthesis, and regulation of mitochondrial function. Aberrant expression of TSPO has been linked to multiple diseases, including cancer, brain injury, neurodegeneration, and ischemia-reperfusion injury. There has been an effort during the last decade to understand the mechanisms regulating tissue- and disease-specific TSPO expression and to identify pharmacological means to control its expression. This review focuses on the current knowledge regarding the chemicals, hormones, and molecular mechanisms regulating Tspo gene expression under physiological conditions in a tissue- and disease-specific manner. The results described here provide evidence that the PKCepsilon-ERK1/2-AP-1/STAT3 signal transduction pathway is the primary regulator of Tspo gene expression in normal and pathological tissues expressing high levels of TSPO.

Indexed as

DiseaseHealthAnimalsGene Expression Regulation, NeoplasticHumansNeoplasmsOrgan SpecificityReceptors, GABAReceptors, GABA

Identifiers

PMID20600583
PMCPMC2922062
OpenAlexW2076945625

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.